NASDAQ: ENLV
Enlivex Therapeutics Ltd Stock Ownership - Who owns Enlivex Therapeutics?

Insider buying vs selling

Have Enlivex Therapeutics Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ENLV insiders and whales buy or sell their stock.

ENLV Shareholders

What type of owners hold Enlivex Therapeutics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Digital Generation Inc45.07%10,750,000$12.69MInsider
James Crabbe13.19%3,145,600$3.71MInsider
Armistice Capital LLC7.47%1,781,931$2.10MInstitution
Millennium Management LLC2.81%669,008$789.43kInstitution
Morgan Stanley0.97%230,685$272.21kInstitution
Dan Isaacs0.84%201,299$237.53kInsider
Adam Moore0.84%201,299$237.53kInsider
Renaissance Technologies LLC0.76%181,289$213.92kInstitution
Jane Street Group LLC0.34%80,759$95.30kInstitution
Citadel Advisors LLC0.29%70,136$82.76kInstitution

1 of 3

ENLV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ENLV13.26%60.25%
OVID65.25%24.06%Net Selling
HYPD1.53%98.47%Net Buying
IGC3.42%24.17%Net Buying
CAMP42.49%57.51%Net Buying

Enlivex Therapeutics Stock Ownership FAQ

Who owns Enlivex Therapeutics?

Enlivex Therapeutics (NASDAQ: ENLV) is owned by 13.26% institutional shareholders, 60.25% Enlivex Therapeutics insiders, and 26.49% retail investors. Digital Generation Inc is the largest individual Enlivex Therapeutics shareholder, owning 10.75M shares representing 45.07% of the company. Digital Generation Inc's Enlivex Therapeutics shares are currently valued at $13.98M.

If you're new to stock investing, here's how to buy Enlivex Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.